Page 4 - Simulations Plus Inc News Today

Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The

Research project with NIEHS includes focus on qualification of in silico methods for prioritization, assessment of risk, and identification of safety margins for chemical use ...

On February 2, 2024, Walter Woltosz, Director and 10% Owner of Simulations Plus Inc (NASDAQ:SLP), sold 20,000 shares of the company's stock, according to a recent SEC Filing.

Simulations Plus, Inc. , a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it will participate in two healthcare...

New version delivers on FDA collaborations and user feedback for expansion of non-oral delivery route models ...

Simulations Plus, Inc. (NASDAQ:SLP – Get Free Report) announced a quarterly dividend on Wednesday, January 3rd, Zacks reports. Stockholders of record on Monday, January 29th will be paid a dividend of 0.06 per share by the technology company on Monday, February 5th. This represents a $0.24 dividend on an annualized basis and a dividend yield […]

Although the stock markets overall enjoyed a banner year in 2023 – the S&P 500 was up 24% – Valley-area stocks, with a few notable exceptions, had a far more modest year.

Partnership aims to integrate experimental data and PBPK modeling to identify key formulation factors to accelerate modified-release product development ...

Simulations Plus, Inc. , a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that, through a joint proposal with Northeastern University and The TIM...

According to a recent SEC filing, Walter Woltosz, a Director and 10% Owner of Simulations Plus Inc (NASDAQ:SLP), has sold 20,000 shares of the company on January 2, 2024.